Isolating One Function From a Multi-Function Hormone
Full-length human growth hormone produces multiple overlapping effects: lipolysis, IGF-1 induction, insulin resistance, cellular proliferation. Research that wants to study one of these effects in isolation has to either use antagonists or use a fragment that retains only the target function.
HGH Fragment 176-191 is the second approach. The research-grade peptide is available as HGH Fragment 176-191 5mg.
The C-Terminal Region
Human growth hormone is a 191-amino-acid protein. Structure-function research has mapped different regions to different effects:
- N-terminal / residues 1-15: Insulin antagonism and glucose metabolism effects
- Middle region: IGF-1 induction via hepatic GH receptor activation
- C-terminal / residues 177-191: Lipolytic activity on adipose tissue
The 176-191 fragment captures the lipolytic region without the segments driving IGF-1 or glucose effects.
Lipolytic Mechanism
The fragment's mechanism involves:
- Beta-3 adrenergic activation in adipose tissue
- Hormone-sensitive lipase upregulation
- Triglyceride hydrolysis and fatty acid release
- Reduced lipogenesis via inhibition of acetyl-CoA carboxylase
The net effect is accelerated fatty acid mobilization without the systemic metabolic effects of full GH.
Why This Matters for Research Design
In full-GH research, teasing apart lipolysis vs IGF-1 vs insulin effects is difficult because all three occur simultaneously. The fragment approach asks: what happens when only the lipolytic axis is engaged?
This enables:
- Lipolysis dose-response studies without IGF-1 confounding
- Adipose-specific research without systemic growth effects
- Comparative research against full-length GH compounds
Handling Notes
Lyophilized HGH Fragment is stable at −20°C long-term. Reconstitution with bacteriostatic water is standard. >98% HPLC purity is the research grade.
For research protocols targeting the lipolytic axis specifically, see HGH Fragment 176-191 5mg.